I too am shocked but keep in mind that this report is probably really being targeted to investors, who are used to paying huge sums of money to get information so they can best invest $$$. And not just theirs, I am talking about investment firms, who can afford this price tag, and want the information so they can advise their clients/investors accordingly. They price it so high so that the average joe-blow cannot afford it, and thus cannot gain any investment advantages without going through the big firms that can pay for reports like this. My two cents.

This report probably includes a fairly comprehensive review of FDA, patent, and other applications, probably here and abroad. Would be neat to have, but at that price, well, that's a lot of meds and DIY therapies!

Thanks for posting this.